KDL Biotech Ltd (KDLB.NS)
KDLB.NS on National Stock Exchange of India
2.50INR
5 Apr 2013
2.50INR
5 Apr 2013
Price Change (% chg)
Rs-0.20 (-7.41%)
Rs-0.20 (-7.41%)
Prev Close
Rs2.70
Rs2.70
Open
Rs2.45
Rs2.45
Day's High
Rs2.50
Rs2.50
Day's Low
Rs2.40
Rs2.40
Volume
1,073
1,073
Avg. Vol
2,217
2,217
52-wk High
Rs4.80
Rs4.80
52-wk Low
Rs1.85
Rs1.85
KDLB.NS
About
KDL Biotech Limited is an India-based company. The Company operates in the Pharmaceuticals segment. The Company’s products include amoxycillin, ampicillin, cloxacillin, dicloxacillin and flucloxacillin.
No analyst recommendations are available for KDLB.NS.
Overall
| Beta: | 1.07 |
| Market Cap (Mil.): | Rs57.68 |
| Shares Outstanding (Mil.): | 24.04 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| KDLB.NS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.37 | 30.65 |
| EPS (TTM): | -7.35 | -- | -- |
| ROI: | -- | 19.50 | 18.83 |
| ROE: | -- | 20.27 | 19.74 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
